Business
COVID-19 vaccine from Johnson & Johnson may be gamechanger – NEWS.com.au
COVID-19 vaccine from Johnson & Johnson may be gamechanger
As the a global COVID-19 vaccine standoff continues, theres a new player in town and this jabs unique quality could be a gamechanger for the rollout.Johnson & Johnson’s product has an overall efficacy of at least 66 per cent, the company announced on Friday, and crucially, the vaccine only requires one dose.
This sets it apart from the other jabs that have been approved in western countries so far from Pfizer/BioNTech, Moderna and Oxford/AstraZeneca. These vaccines all require two shots, given several…
-
Business22 hours agoThe pros and cons of buying CBA shares in September
-
Noosa News22 hours agoRent changes on way for hundreds of social housing recipients following government review
-
Business18 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News20 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses